XERAVA Trademark

Trademark Overview

On Friday, February 2, 2018, a trademark application was filed for XERAVA with the United States Patent and Trademark Office. The USPTO has given the XERAVA trademark a serial number of 87782461. The federal status of this trademark filing is REGISTERED as of Tuesday, September 24, 2019. This trademark is owned by Tetraphase Pharmaceuticals, Inc.. The XERAVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis
xerava

General Information

Serial Number87782461
Word MarkXERAVA
Filing DateFriday, February 2, 2018
Status700 - REGISTERED
Status DateTuesday, September 24, 2019
Registration Number5869102
Registration DateTuesday, September 24, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceuticals, namely, antibiotics indicated for the treatment of infections; the aforementioned not for the treatment of rheumatoid arthritis or psoriasis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 12, 2018
Primary Code005
First Use Anywhere DateThursday, October 11, 2018
First Use In Commerce DateThursday, October 11, 2018

Trademark Owner History

Party NameTetraphase Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameTetraphase Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameTetraphase Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Wednesday, May 16, 2018ASSIGNED TO EXAMINER
Tuesday, February 6, 2018NEW APPLICATION ENTERED
Monday, February 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 22, 2018NON-FINAL ACTION WRITTEN
Tuesday, May 22, 2018NON-FINAL ACTION E-MAILED
Tuesday, May 22, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 5, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 17, 2018ASSIGNED TO LIE
Wednesday, July 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 18, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 18, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 19, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2018EXTENSION OF TIME TO OPPOSE RECEIVED
Friday, February 15, 2019OPPOSITION INSTITUTED NO. 999999
Monday, April 15, 2019OPPOSITION TERMINATED NO. 999999
Monday, April 15, 2019OPPOSITION DISMISSED NO. 999999
Monday, April 15, 2019TTAB RELEASE CASE TO TRADEMARKS
Wednesday, April 24, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 24, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, July 25, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, August 21, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 24, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, July 25, 2019USE AMENDMENT FILED
Wednesday, August 21, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 21, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 28, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 28, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED

Related Keywords

xerava treatment rheumatoid arthritis psoriasis aforementioned infections antibiotics indicated pharmaceuticals namely